Demineralized bone fiber market seen reaching $1.97 billion by 2030

The demineralized bone fiber technology market is projected to rise from $1.43 billion in 2025 to $1.53 billion in 2026, driven by orthopedic, dental and spinal procedures. The Business Research Company expects the market to keep growing at a 6.5% annual pace through 2030 as biologic grafts gain broader use.

Why it matters: - Demineralized bone fiber technology is becoming a bigger part of bone repair in orthopedic and dental care. - The market’s expected growth points to rising demand for graft materials that support bone regeneration and can be used in more procedures. - The shift matters for hospitals, surgeons and implant providers as procedure volumes increase and biologic alternatives gain acceptance.

What happened: - The Business Research Company released a report on the demineralized bone fiber technology market covering 2026 through 2035. - The market is projected to rise from $1.43 billion in 2025 to $1.53 billion in 2026. - The report puts the market on track to reach $1.97 billion by 2030. - The forecast assumes a 6.5% compound annual growth rate across the period. - North America was the largest regional market in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - A free sample and the full report are available online.

The details: - Demand is being lifted by more orthopedic surgeries, more traumatic bone injury cases and more dental implant procedures. - Hospital-based orthopedic services are expanding and adding to adoption. - Better clinical acceptance of allograft materials is also supporting the market. - Demineralized bone fiber technology removes mineral content from human or animal bone while preserving the collagen matrix. - The process creates a flexible graft material that supports bone healing and regeneration. - The material is mainly used in orthopedic and dental procedures. - Its osteoinductive properties help stimulate new bone growth at the implantation site. - The report cites an aging global population, higher demand for minimally invasive bone repair, more spinal fusion surgeries and more dental restoration procedures as long-term growth drivers. - The report also points to greater use of biologic graft substitutes and ready-to-use grafting solutions. - Emerging trends include more osteoinductive graft materials, broader spinal fusion use, more flexible graft formats and expanded dental bone regeneration applications.

Between the lines: - The market is moving away from purely synthetic options and toward biologic graft substitutes that fit more procedures and reduce preparation burden. - Faster growth in Asia-Pacific suggests adoption is spreading beyond mature markets as surgical capacity and dental restoration demand increase. - Rising musculoskeletal disease prevalence supports the case for more regenerative bone therapies. - UK data cited in the report shows 18.4% of people aged 16 and older reported long-term musculoskeletal conditions in 2023, up from 17.6% in 2022.

What's next: - The market is expected to keep expanding through 2030 if orthopedic, spinal and dental procedure volumes continue climbing. - Broader use of ready-to-use and flexible graft formats could shape product development and purchasing decisions. - Asia-Pacific’s growth rate will likely determine how quickly the market’s center of gravity shifts away from North America.

The bottom line: - Demineralized bone fiber technology is positioned for steady mid-single-digit growth as bone repair needs rise across orthopedic, spinal and dental care.